A soft, high strength thermoplastic elastomeric composition for use in medical and pharmaceutical products, comprising an ethylene butylene block copolymer having terminal polystyrene units, a platicizer in an amount sufficient to soften the ethylene butylene phase of the copolymer, and a thermoplastic acrylic resin in an amount ranging from 15 to 65 parts per 100 parts of the copolymer.

Patent
   4814375
Priority
Sep 24 1987
Filed
Sep 24 1987
Issued
Mar 21 1989
Expiry
Sep 24 2007
Assg.orig
Entity
Large
28
9
EXPIRED
1. A soft, high strength thermoplastic elastomeric composition having clarity and a shore A hardness of less than about 30 and a tensile strength greater than 1500 psi, comprising:
an ethylene butylene block copolymer having terminal polystyrene units;
a quantity of mineral oil in an amount ranging from about 70 to about 150 parts per 100 parts of copolymer; and
a thermoplastic lower alkyl acrylate polymer in an amount ranging from about 15 to about 40 parts per 100 parts of copolymer, said polymer formed from monomers consisting of one or more lower alkyl acrylate monomers.
4. A soft, high strength thermoplastic elastomeric composition having a shore A hardness of less than about 30 and a tensile strength greater than about 1500 psi for use in medical and pharmaceutical products, consisting essentially of a homogeneous blend of:
an ethylene butylene block copolymer having terminal polystyrene units;
a high boiling point petroleum distillate plasticizer in an amount ranging from about 70 to about 150 parts per 100 parts of said copolymer; and
a thermoplastic acrylic lower alkyl acrylate polymer in an amount ranging from about 15 to about 40 parts per 100 parts of said copolymer, said polymer being formed from monomers consisting of one or more lower alkyl acrylate monomers.
2. The elastomer of claim 1, which is formed by melt mixing.
3. The composition of claim 1, wherein the alkyl group is selected from methyl, ethyl and butyl.
5. The composition of claim 4, which is formed by melt mixing.
6. The composition of claim 4, wherein said petroleum distillate is mineral oil.
7. The composition of claim 6, wherein said mineral oil is present in an amount ranging from about 70 to about 150 parts per 100 parts of copolymer.
8. The composition of claim 4, wherein the alkyl group is selected from methyl, ethyl and butyl.

This invention relates to soft thermoplastic elastomeric compositions which are soft and have high tensile strength.

The need for a soft, strong, thermoplastic elastomer for pharmaceutical or medical products continues to exist even though many new materials have been developed. Some materials have some of the desired properties, to some degree. Silicone can be formulated into soft, strong, products but in many applications, silicone products are far too expensive, particularly when large quantities of the products are to be produced. Nothing presently available gives a unique combination of low hardness and useful strength at a resonable cost. Particularly of interest would be products having low hardness and high strength along with some amount of clarity.

Various combinations of synthetic materials have been attempted in order to achieve various end product properties. In U.S. Pat. No. 4,598,123, clear cast acrylic sheets of improved impact strength are prepared by dissolving or dispersing a minor amount of an ABA block copolymer into a methyl methacrylate casting mixture which contains some styrene, followed by polymerization in sheet form via heating with an initiator. The resulting product had improved impact resistance and some formulations remained clear. The hardness, based on the Rockwell R Scale, was at least 77, indicating a very hard product.

Another formulation is described in U.S. Pat. No. 4,440,815. In this patent, 45% to 70% by weight of a polyolefin such as polypropylene is mixed with from 5% to 25% of an ethylene/lower alkyl acrylate copolymer and 10% to 40% of an ethylene butulene block copolymer having terminal styrene blocks. The material is stated to be suitable for sheet extrusion, injection molding or blow molding into flexible, transparent, autoclavable intravenous solution containers which withstand heavy impact during shipment and which also is sufficiently flexible to collapse during drainage of intravenous solutions. The product produced in Example 4 of that patent indicates a hardness on a Shore A Scale of 52, which is still considered to be very hard for many applications.

A strong and soft theromplastic elastomer is still not available for the medical and pharmaceutical industries. Such an elastomer, particularly if it could be produced with some clarity, would form the basis of many practical and useful formulations.

The present invention provides a new thermoplastic elastomeric composition which is admirably suited for use in the medical and pharmaceutical industry. The thermoplastic elastomer is soft and strong, so that it can be made into a variety of products. Some formulations produce clear products.

Specifically, the instant invention provides a soft, high strength thermoplastic elastomeric composition which comprises an ethylene butylene block copolymer having terminal polystyrene units, a plasticizer in an amount sufficient to soften the ethylene butylene phase of the copolymer, and a thermoplastic acrylic resin in an amount ranging from 15 to 65 parts per 100 parts of the block copolymer.

The elastomer is formed simply by melt blending and incurs no mixing, temperature or processing problems.

The preferred plasticizer is a high boiling point petroleum distillate such as mineral oil, and is contained in an amount ranging from about 30 to 150 parts of plasticizer per 100 parts of block copolymer. Another preferred plasticizer is a high molecular weight polybutene. Preferred thermoplastic acrylic resins are lower alkyl acrylate polymers or copolymers, particularly where the alkyl group is selected from methyl, ethyl and butyl. A preferred range for the amount of resin ranges from about 15 to 40 parts per one hundred parts of said block copolymer.

Products having a Shore A hardness of less than 40, and in some instance less than 20 or 25, are strong, having a tensile strength above 1500 PSI or even 2000 psi or more.

Many of the thermoplastic elastomers which comprise the present invention have an optical clarity which is very desirable and which is also unexpected. Products containing (1) the ethylene butylene block copolymer with terminal polystyrene units, (2) a plasticizer and (3) a thermoplastic acrylic resin are formulated with conventional additives to produce thermoplastic elastomers which have many uses in the medical and pharmaceutical industries. The high strength, low modulus and the softness which these compositions have, makes these thermoplastic elastomers highly suitable as the foundation material which can be fabricated into a variety of products. Particularly of interest are soft, strong baby bottle nipples, especially those which have at least some degree of clarity.

The ethylene butylene block copolymers which form a basic component of the present thermoplastic elastomer are ethylene butylene copolymers which have terminal polystyrene units. These polymers are commercially available from Shell Chemical Company under the trademark Kraton G. Block copolymers described in U.S. Pat. No. 3,686,364 and U.S. Pat. No. 3,865,776 are typical examples of the block copolymers contemplated by the present invention. In the latter patent, assigned to Shell Oil Company, copolymers are described as having ethylene butylene central blocks of from 50 to 80 percent by weight of the copolymer molecule in approximately equal proportions of ethylene and butylene. The terminal blocks are polystyrene. These ethylene butylene block copolymers having terminal polystyrene units are referred to by the shorthand designation of SEBS copolymers. This basic component of the thermoplastic elastomers of the present invention is present in an amount by weight ranging from about 30% to about 70%. However, for the purposes of describing the products, the formulations ar based on 100 parts of SEBS.

The above referenced patents which describe the SEBS copolymers describe the use of various plasticizers which function to soften the ethylene butylene phase of the copolymer. This increases the processability of SEBS as well as modifies the final product properties. A typical plasticizer is a petroleum distillate byproduct usually having a relatively high boiling point. One preferred example of a plasticizer is mineral oil. The amount of mineral oil which is employed is sufficient to soften the ethylene butylene phase of the SEBS copolymer. Tyipcally, this amount will range from 30 to about 150 parts per 100 parts of SEBS. More preferred is a range from about 70 to 150 parts of plasticizer and most preferably between 70 and 110 parts of plasticizer per 100 parts of SEBS.

The remaining component of the high strength soft thermoplastic elastomeric compositions is a thermoplastic acrylic resin in an amount ranging from about 15 to about 65 parts per 100 parts of SEBS copolymer. Preferred thermoplastic acrylic resins are the lower alkyl acrylate polymers or copolymers, particularly those where the alkyl group is selected from methyl, ethyl and butyl.

One preferred source of acrylic resins are the thermoplastic acrylic ester resins manufactured under the tradename ACRYLOID by the Rohm and Haas Company. These lower alkyl acrylate polymers or copolymers primarily have alkyl groups selected from methyl, ethyl and butyl.

A number of experiments were performed to demonstrate the efficacy of this invention. In each case, the formulation was prepared by making a dry blend of the mixture of SEBS, plasticizer and acrylic resin. These materials were melt mixed in a Banbury mixer and granulated. The particles were then molded to make samples which were then evaluated as will be described below. The samples prepared for the examples described herein presented no mixing problems, had no processing difficulties and did not require unusual melt temperatures. Other variations of conventional techniques for making thermoplastic elastomeric compositions may be used as well.

Physical properties were measured on a series of thermoplastic compositions containing different thermoplastic acrylic resins in formulations with 100 parts of SEBS and 80 parts mineral oil as a plasticizer. All of these various thermoplastic acrylic resins combined to form soft, strong thermoplastic elastomeric compositions which had clarity. The hardness was measured using a Shore A durometer and the tensile strength by ASTM standard methods was also measured. Presented below in Table I are the results of various tests made from a series of different thermoplastic acrylic resins containing compositions according to the invention. As will be noted, the thermoplastic elastomeric composition were soft, having a Shore A hardness of less than 40 and were strong, having a tensile strength of at least 1500. All of the products produced were clear. These results are surprising.

TABLE I
______________________________________
Thermoplastic acrylic
resin, 15 parts with
Example
100 parts SEBS and 80
Hardness, Tensile,
Number parts mineral oil
Shore A PSI Clear
______________________________________
1 methyl methacrylate
36 1640 Yes
2 isobutyl methacrylate
34 1770 Yes
3 methyl/butyl meth-
31 1670 Yes
acrylate
4 ethyl methacrylate
30 1990 Yes
5 methyl/butyl meth-
29 1760 Yes
acrylate
______________________________________

As can be seen, a variety of thermoplastic acrylic resins are capable of producing clear, soft, strong thermoplastic elastomers for use in the medical and pharmaceutical industry. All of the experiments shown in Table I have produced clear thermoplastic elastomers.

Additional experiments were performed, using the methyl/butyl methacrylate copolymer of Example 5 above, in order to produce products with varying quantities of plasticizer or acrylic resins. As can be seen in Table II below, the amount of plasticizer and the amount of acrylic resin can be varied greatly while still producing soft, strong quality products. It should be noted that a formulation without plasticizer produced a very hard product, while a formulation without the acrylic resin has substantially no strength.

TABLE II
______________________________________
Mineral Oil,
Acrylic Resin,
Example
parts per 100
parts per 100
Hardness
Tensile
Number parts SEBS parts SEBS Shore A PSI
______________________________________
6 0 40 93 2690
7 110 0 10 60
8 70 15 36 1690
9 80 15 30 1800
10 90 15 26 1680
11 110 15 22 1520
12 80 25 35 1620
13 100 25 25 1770
14 90 35 35 1840
15 110 35 27 1560
16 110 40 28 1580
17 150 40 18 1530
18 100 45 34 1620
______________________________________

Formulation of several of the above examples were molded into soft, strong plastic objects useful for the pharmaceutical and medical industries. The resulting products can be manufactured into baby bottle nipples, tubing and the like. Formulations as described above, with a hardness of less than 40, Shore A, and a tensile strength above 1500 have great utility in the pharmaceutical industry. These formulations demonstrate superior softness along with a strength and integrity above that which is required.

Ingredients such as antioxidants, fillers, coloring agents, processing aids, and other conventional additives normally used in the formulation of thermoplastic elastomers may be used in specific formulations when practicing the present invention.

While particular embodiments of the present invention have been illustrated and described herein, it is not intended to limit the invention and changes and modifications may be made therein within the scope of the following claims.

Esposito, Anthony S.

Patent Priority Assignee Title
4891381, Dec 16 1986 Rotta Research Laboratorium Derivatives of 5-pentylamino-5-oxopentanoil and 4-pentlamino-4-oxobutanoic acids with antagonistic activity towards cholecystokinin
5324580, Sep 30 1991 Fiberweb Holdings Limited Elastomeric meltblown webs
6288159, Aug 12 1996 CHURCH & DWIGHT CO , INC S-EB-S block copolymer/oil aqueous dispersion and its use in forming articles
6303200, Jan 27 1998 Baxter International Inc Low modulus and autoclavable monolayer medical tubing
6414083, Aug 12 1996 CHURCH & DWIGHT CO , INC S-EB-S block copolymer/oil aqueous dispersion and its use in forming articles
6764761, May 24 2002 BAXTER INTERNATIONAL, INC ; BAXTER HEALTHCARE S A Membrane material for automated dialysis system
6964688, Jul 31 1996 Ohio Willow Wood Company Tube sock-shaped covering
6984688, May 02 2003 Avient Corporation Injection-moldable transparent thermoplastic elastomer
7271209, Aug 12 2002 ExxonMobil Chemical Patents INC Fibers and nonwovens from plasticized polyolefin compositions
7291182, Mar 05 1996 The Ohio Willow Wood Company Gel and cushioning devices
7531594, Aug 12 2002 ExxonMobil Chemical Patents INC Articles from plasticized polyolefin compositions
7569262, Feb 01 2001 Renolit AG Flexible monolayer elastomer films and bag for medical use
7619026, Aug 12 2002 ExxonMobil Chemical Patents INC Plasticized polyolefin compositions
7622523, Aug 12 2002 ExxonMobil Chemical Patents Inc. Plasticized polyolefin compositions
7632887, Aug 12 2002 ExxonMobil Chemical Patents INC Plasticized polyolefin compositions
7875670, Aug 12 2002 ExxonMobil Chemical Patents Inc. Articles from plasticized polyolefin compositions
7985801, Aug 12 2002 ExxonMobil Chemical Patents Inc. Fibers and nonwovens from plasticized polyolefin compositions
7998579, Aug 12 2002 ExxonMobil Chemical Patents INC Polypropylene based fibers and nonwovens
8003725, Aug 12 2002 ExxonMobil Chemical Patents INC Plasticized hetero-phase polyolefin blends
8192813, Aug 12 2003 ZURN PEX, INC Crosslinked polyethylene articles and processes to produce same
8211968, Aug 12 2002 ExxonMobil Chemical Patents Inc. Plasticized polyolefin compositions
8217112, Aug 12 2002 ExxonMobil Chemical Patents Inc. Plasticized polyolefin compositions
8317873, Feb 23 2010 APOGEM CAPITAL LLC, AS SUCCESSOR AGENT Polymeric prosthetic liner with controlled stretch characteristics
8389615, Dec 17 2004 ExxonMobil Chemical Patents INC Elastomeric compositions comprising vinylaromatic block copolymer, polypropylene, plastomer, and low molecular weight polyolefin
8513347, Jul 15 2005 ExxonMobil Chemical Patents INC Elastomeric compositions
8523951, Jul 31 1996 The Ohio Willow Wood Company Prosthetic socket interface and assembly
8703030, Aug 12 2003 ExxonMobil Chemical Patents Inc.; Zurn Pex, Inc. Crosslinked polyethylene process
9265629, Apr 01 2011 APOGEM CAPITAL LLC, AS SUCCESSOR AGENT Fabric covered polymeric prosthetic liner
Patent Priority Assignee Title
3562356,
3792124,
4107233, Aug 30 1976 Shell Oil Company Block copolymer blend with certain acrylics
4199490, May 07 1974 Asahi Kasei Kogyo Kabushiki Kaisha Block copolymer latex composition
4264747, Jul 14 1980 Uniroyal Chemical Company, Inc High impact strength styrene-acrylonitrile resin blend
4286077, Apr 21 1980 Shell Oil Company Weather resistant adhesive composition
4393170, Apr 30 1980 Phillips Petroleum Company Polymeric blends
4440815, Jun 29 1981 Abbott Laboratories Clear, autoclavable plastic formulation for medical liquid containers
4588777, Oct 21 1982 Dainippon Plastics Co., Ltd. Synthetic resin composition
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Sep 15 1987ESPOSITO, ANTHONY S WEST COMPANY, THE, WEST BRIDGE STREET PHOENIXVILLE, PA 19460 A CORP OF PA ASSIGNMENT OF ASSIGNORS INTEREST 0047960503 pdf
Sep 24 1987The West Company(assignment on the face of the patent)
Date Maintenance Fee Events
Apr 20 1992M183: Payment of Maintenance Fee, 4th Year, Large Entity.
Jun 03 1992ASPN: Payor Number Assigned.
Oct 29 1996REM: Maintenance Fee Reminder Mailed.
Feb 04 1997ASPN: Payor Number Assigned.
Feb 04 1997RMPN: Payer Number De-assigned.
Mar 23 1997EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Mar 21 19924 years fee payment window open
Sep 21 19926 months grace period start (w surcharge)
Mar 21 1993patent expiry (for year 4)
Mar 21 19952 years to revive unintentionally abandoned end. (for year 4)
Mar 21 19968 years fee payment window open
Sep 21 19966 months grace period start (w surcharge)
Mar 21 1997patent expiry (for year 8)
Mar 21 19992 years to revive unintentionally abandoned end. (for year 8)
Mar 21 200012 years fee payment window open
Sep 21 20006 months grace period start (w surcharge)
Mar 21 2001patent expiry (for year 12)
Mar 21 20032 years to revive unintentionally abandoned end. (for year 12)